Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity

NCT00729469 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

919

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrophy
Vaginal Diseases

Interventions

DRUG: Ospemifene 60 mg
DRUG: Placebo

Sponsor

Shionogi

Collaborators

[object Object]
[object Object]